Autologous Skeletal Myoblast Sheet Therapy for Porcine Myocardial Infarction Without Increasing Risk of Arrhythmia.

Safety concerns of ventricular tachyarrhythmia have arisen from some clinical trials of autologous skeletal myoblast (SkM) injection therapy. This study examined the effect and safety of SkM sheet therapy in a pig model of chronic myocardial infarction. Minipigs underwent LAD occlusion using a balloon catheter for 2 h, followed by reperfusion. After 28 days, 12 SkM sheets were transplanted onto the infarcted myocardium (sheet group n = 8); the same number of cells was also injected into the myocardium (injection group n = 7), and sham operations were performed as a control (sham group n = 7). Implantable ECG loop recorders (ILR) were placed subcutaneously on the left thorax. At 28 days after transplantation, we assessed cardiac function with MDCT, interrogated ILR, and performed programmed ventricular stimulation (PVS), after which organs were harvested for histopathology. To assess the inflammatory and injury response, inflammation factors and high-sensitive CRP and troponin I were measured at 1, 3, 7, and 28 days after transplantation by the cytokine array method and ELISA, respectively. The sheet group showed an improvement in cardiac function compared with both the injection and sham groups (LVEF change: 5.8 ± 2.7%, -1.0 ± 2.6%, and -3.8 ± 1.8% in the sheet, injection, and sham groups, respectively, p < 0.05). VF was not detected in any group using ILR, while VT was detected in one pig from the injection group. VF was induced in 25.0%, 71.4%, and 28.6% of animals in the sheet, injection, and sham groups, respectively. In the injection group, anti-macrophage-positive cells were observed around the injected cells within the myocardium. Transmission electron microscopic images showed differentiated myofilaments, collagen layers, and a characteristic extracellular matrix surrounding the SkMs in the sheet group. Toroponin I and IL-6 levels were higher in the injection group compared with both the sheet and sham groups. SkM sheets transplanted onto infarcted myocardium improved cardiac function over SkM injection without increasing arrhythmogenicity.

[1]  Y. Sawa,et al.  The use of cell-sheet technique eliminates arrhythmogenicity of skeletal myoblast-based therapy to the heart with enhanced therapeutic effects. , 2013, International journal of cardiology.

[2]  Teruo Okano,et al.  Tissue engineered myoblast sheets improved cardiac function sufficiently to discontinue LVAS in a patient with DCM: report of a case , 2012, Surgery Today.

[3]  Marcus F Stoddard,et al.  Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial , 2011, The Lancet.

[4]  R. Roberts,et al.  A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction. , 2011, American heart journal.

[5]  Masayuki Yamato,et al.  Cardiac cell sheet transplantation improves damaged heart function via superior cell survival in comparison with dissociated cell injection. , 2011, Tissue engineering. Part A.

[6]  Teruo Okano,et al.  Impaired Myocardium Regeneration With Skeletal Cell Sheets—A Preclinical Trial for Tissue-Engineered Regeneration Therapy , 2010, Transplantation.

[7]  関谷 直純.  Layered implantation of myoblast sheets attenuates adverse cardiac remodeling of the infarcted heart , 2009 .

[8]  Teruo Okano,et al.  Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. , 2009, The Journal of clinical investigation.

[9]  M. Yacoub,et al.  A Factor Underlying Late-Phase Arrhythmogenicity After Cell Therapy to the Heart: Global Downregulation of Connexin43 in the Host Myocardium After Skeletal Myoblast Transplantation , 2008, Circulation.

[10]  Guy Salama,et al.  Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia , 2007, Nature.

[11]  G. Marenzi,et al.  Improved clinical outcome after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. , 2007, European heart journal.

[12]  K. Osterziel.  Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1 year results of the REPAIR-AMI trial. , 2006, European heart journal.

[13]  G. Gaudette,et al.  Inflammation effects on the electrical properties of atrial tissue and inducibility of postoperative atrial fibrillation. , 2006, The Journal of surgical research.

[14]  Hidezo Mori,et al.  Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction , 2006, Nature Medicine.

[15]  T. Okano,et al.  Tissue Cardiomyoplasty Using Bioengineered Contractile Cardiomyocyte Sheets to Repair Damaged Myocardium: Their Integration with Recipient Myocardium , 2005, Transplantation.

[16]  Teruo Okano,et al.  Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets. , 2005, The Journal of thoracic and cardiovascular surgery.

[17]  M. Rubart,et al.  Spontaneous and evoked intracellular calcium transients in donor-derived myocytes following intracardiac myoblast transplantation. , 2004, The Journal of clinical investigation.

[18]  A. Hagège,et al.  Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. , 2003, Journal of the American College of Cardiology.

[19]  F. Pagani,et al.  Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. , 2003, Journal of the American College of Cardiology.

[20]  Stefan Fischer,et al.  In vitro engineering of heart muscle: artificial myocardial tissue. , 2002, The Journal of thoracic and cardiovascular surgery.

[21]  Mitsuo Umezu,et al.  Fabrication of Pulsatile Cardiac Tissue Grafts Using a Novel 3-Dimensional Cell Sheet Manipulation Technique and Temperature-Responsive Cell Culture Surfaces , 2002, Circulation research.

[22]  C. Murry,et al.  Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. , 2000 .

[23]  W. Zimmermann,et al.  Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. , 2000, Biotechnology and bioengineering.

[24]  R. Weisel,et al.  Survival and function of bioengineered cardiac grafts. , 1999, Circulation.

[25]  T. Okano,et al.  A novel recovery system for cultured cells using plasma-treated polystyrene dishes grafted with poly(N-isopropylacrylamide). , 1993, Journal of biomedical materials research.

[26]  M. Cheitlin.  Adult Bone Marrow–Derived Cells for Cardiac Repair: A Systematic Review and Meta-analysis , 2008 .